Results 241 to 250 of about 178,510 (340)
Atopic dermatitis and the risk of osteoporosis and fractures: a meta-analysis of cohort studies. [PDF]
Liu H, Ru H, Yu P, Wei W, Wang S.
europepmc +1 more source
Anti-Cytokine Drugs in the Treatment of Canine Atopic Dermatitis. [PDF]
Wichtowska A, Olejnik M.
europepmc +1 more source
Atopic Comorbidities and Topical Steroids in Early Childhood Atopic Dermatitis: Are We Missing a Piece of the Puzzle? [PDF]
Chau CA, Cyr SL, Gupta R, Lio P.
europepmc +1 more source
ABSTRACT Background With increasing use of intrapartum antibiotic prophylaxis (IAP) for the prevention of early‐onset Group B streptococcus (GBS) infections, there is concern about its long‐term consequences on child health. Objectives To synthesise the evidence of IAP exposure on autoimmune‐related diseases, obesity in childhood and microbial ...
Maedeh Moradi +3 more
wiley +1 more source
Skin adverse events (AEs) frequently accompany all types of anticancer treatments. This publication discusses how recent international guidance on best‐practices use of dermocosmetics can be adapted to the North Asia region (China, Hong Kong, Japan, Republic of Korea, and Taiwan).
Meng Pan +9 more
wiley +1 more source
The assessment of quality of life in adult patients with atopic dermatitis
Silvana Lessi Coghi
openalex +1 more source
Skin and gut microbiome in atopic dermatitis: Mechanisms and therapeutic opportunities. [PDF]
Hou B, Shao H, Yuan D, Tham EH.
europepmc +1 more source
Targeted Systemic Therapies for Atopic Dermatitis in Australia: A Narrative Review
ABSTRACT Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease estimated to affect approximately 30% of children and 10%–15% of adults in Australia. Of those with this condition, one in five is estimated to have moderate‐to‐severe disease.
Diana Rubel +5 more
wiley +1 more source

